This article has been updated with charging information from the Hennepin County (Minn.) Attorney’s Office. Officials in Minneapolis have charged a man with manslaughter in the August 23, 2019, death of a Medtronic research scientist. Hennepin County officials said they have charged Erik Kravchuk, 28, of Golden Valley, Minn. with first-degree manslaughter in the death […]
Medtronic recalls certain balloon catheters
Medtronic is voluntarily recalling certain balloon dilation catheters that have proven difficult to remove from patients’ bodies. The recall affects a subset of the company’s Euphora and Solarice semi-compliant rapid exchange balloon dilatation catheters manufactured from February 27, 2019, through July 31, 2019, according to a letter sent to customers. Medtronic said that some of […]
Medtronic letter reveals Micra pacemaker deployment troubles
Medtronic has been fielding complaints from physicians who have had trouble releasing the company’s Micra pacemaker from its delivery system inside patients’ bodies. In a letter dated August 2019, the company noted that it had received 52 complaints worldwide involving a tangled tether that resulted in prolonged or additional procedures. Specifically, the company said it […]
Medtronic lands reimbursement for MiniMed 670G pump in Germany
Medtronic (NYSE:MDT) said today it has secured reimbursement for its MiniMed 670G insulin pump system from regulators in Germany. The German Federal Association of the Statutory Health Insurances (GKV-SV) granted reimbursement for the smart insulin pump for patients with type 1 diabetes, according to the company. Get the full story on our sister site, Drug Delivery […]
Medtronic’s In.Pact AV DCB meets endpoints in trial
Medtronic (NYSE:MDT) said last week that its clinical study comparing the In.Pact AV drug-coated balloon to percutaneous transluminal angioplasty (PTA) met primary safety and effectiveness endpoints. The study pitted the In.Pact AV DCB against PTA in patients with de novo or non-stented restenotic arteriovenous fistulae lesions. Results were presented at the Cardiovascular and Interventional Radiology Society […]
Here’s how Omar Ishrak transformed Medtronic into the world’s largest medtech operation
Omar Ishrak used a series of M&A moves and focus on global markets and value-based care to transform Medtronic (NYSE:MDT) into the world’s largest medical device business in less than a decade. Ishrak is preparing to retire from the corner office next year ahead of the medtech giant’s mandatory retirement age, to be replaced by […]
Surmodics reaps $10m from Abbott on SurVeil balloon milestone
Surmodics (NSDQ:SRDX) said today that it’s due for a $10 million milestone payment from Abbott (NYSE:ABT) after closing enrollment for the Transcend pivotal trial of its SurVeil drug-coated balloon for treating peripheral artery disease. Abbott in February 2018 paid $25 million up front for the global commercialization rights to the SurVeil device, which uses a proprietary […]
BREAKING: Martha to succeed Ishrak as Medtronic CEO
Medtronic (NYSE:MDT) said today that executive vice president Geoff Martha is slated to succeed Omar Ishrak as CEO next year, ahead of the medtech giant’s mandatory retirement age. Ishrak is slated to assume the newly created executive chairman role April 27, 2020, the Fridley, Minn.-based company said, providing “counsel and guidance to Medtronic’s leadership, oversee […]
Appeals court upholds Medtronic win in wrongful termination suit
A federal appeals court yesterday upheld a win for Medtronic (NYSE:MDT) in a wrongful termination lawsuit brought by an employee who alleged that he was fired because of his morbid obesity. Jose Valtierra weighed more than 300 pounds when he was hired as a facility maintenance technician in 2004; by the time he was fired […]
Study: No difference between Biotronik, Medtronic or Boston Scientific stents
A study comparing drug-eluting stents made by Biotronik, Medtronic (NYSE:MDT) and Boston Scientific (NYSE:BSX) found no statistically significant difference on target vessel failure or stent thrombosis after three years. The 3,514-patient Bio-Resort trial compared Biotronik’s Orsiro biodegradable sirolimus-eluting stent, Medtronic’s thin-strut zotarolimus-eluting Resolute Integrity stent and the Synergy biodegradable everolimus-eluting stent. Get the full story at […]
Medtronic’s fiscal Q1 numbers top estimates
Medtronic (NYSE:MDT) posted fiscal first-quarter results today that beat the consensus forecast on Wall Street for both sales and earnings. The Fridley, Minn.-based medical device titan reported profits of $864.0 million, or 64¢ per share, on sales of $7.49 billion for the three months ended July 26, amounting to a bottom-line slide of -19.6% on […]
- 1
- 2
- 3
- …
- 78
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube